Login / Signup

Serially Measured hs-cTnT, NT-proBNP, hs-CRP and GDF-15 for Risk Assessment After Acute Coronary Syndrome: the BIOMArCS Cohort.

Muhammed T GürgözeK Martijn AkkerhuisRohit M OemrawsinghVictor A W M UmansBas KietselaerCarl E SchotborghEelko RonnerTimo LenderinkIsmail AksoyPim van der HarstFolkert W AsselbergsArthur C MaasAnton J Oude OphuisBoudewijn KrenningRobbert J de WinterSalem H K TheAlexander J WardehWalter R M HermansG Etienne CramerIna van GorpYolanda B de RijkeRon H N van SchaikEric Boersma
Published in: European heart journal. Acute cardiovascular care (2023)
The Netherlands Trial Register. Currently available at URL https://trialsearch.who.int/; Unique Identifiers: NTR1698 and NTR1106.
Keyphrases
  • acute coronary syndrome
  • risk assessment
  • phase iii
  • percutaneous coronary intervention
  • study protocol
  • antiplatelet therapy
  • phase ii
  • human health
  • clinical trial
  • randomized controlled trial
  • open label